Ampio Pharm Analysis

Ampio Pink Sheet Analysis Notes

The company has price-to-book (P/B) ratio of 0.21. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ampio Pharm recorded a loss per share of 10.66. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 12th of September 2023. Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.The quote for Ampio Pharm is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Ampio Pharm please contact Michael Martino at 720 437 6500 or go to https://ampiopharma.com.

Ampio Pharm Investment Alerts

Ampio Pharm Upcoming and Recent Events

Ampio Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 340.61 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ampio Pharm's market, we take the total number of its shares issued and multiply it by Ampio Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 25th of April, Ampio Pharm shows the Mean Deviation of 6.61, standard deviation of 11.8, and Risk Adjusted Performance of (0.10). Ampio Pharm technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Ampio Pharm, which can be compared to its peers. Please confirm Ampio Pharm variance and value at risk to decide if Ampio Pharm is priced correctly, providing market reflects its regular price of 0.25 per share. As Ampio Pharm appears to be a penny stock we also recommend to validate its jensen alpha numbers.

Ampio Pharm Price Movement Analysis

Ampio Pharm Insider Trading Activities

Ampio Pharm Predictive Daily Indicators

Ampio Pharm Forecast Models

Ampio Pharm's time-series forecasting models are one of many Ampio Pharm's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ampio Pharm's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Ampio Pharm prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ampio shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Ampio Pharm. By using and applying Ampio Pink Sheet analysis, traders can create a robust methodology for identifying Ampio entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ampio Pharm. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.